Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Kimihiro Shimizu"'
Autor:
Mitsuyoshi Utsugi, Reiko Sakurai, Noriaki Sunaga, Akira Mogi, Yoshio Tomizawa, Tomohito Kuwako, Tomomi Masuda, T. Ishizuka, Kyoichi Kaira, Atsushi Takise, Yosuke Miura, Ryusei Saito, Kimihiro Shimizu, Kaori Seki, Koichi Minato, Masanobu Yamada, Hisao Imai, Shinichi Ishihara, Takeshi Hisada
Publikováno v:
Cancer Chemotherapy and Pharmacology
Purpose In patients with epidermal growth factor receptor (EGFR)-mutated, advanced, non-small cell lung cancer (NSCLC), common gefitinib-sensitive EGFR mutations that predict a greater response to therapy include the exon 19 deletion and L858R point
Autor:
Yoshio Tomizawa, Kimihiro Shimizu, Masanobu Yamada, Ryusei Saito, Koichi Minato, Tomohito Kuwako, Tomomi Masuda, T. Ishizuka, Kaori Seki, Kyoichi Kaira, Noriaki Sunaga, Reiko Yoshino, Mitsuyoshi Utsugi, Akira Mogi, Hisao Imai, Atsushi Takise, Yosuke Miura, Shinichi Ishihara, Takeshi Hisada
Publikováno v:
Cancer Chemotherapy and Pharmacology. 76:761-769
The efficacy of gefitinib [an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor] in elderly patients with non-small cell lung cancer (NSCLC) and EGFR mutation has not been elucidated. Therefore, the objective of this study was to inve